House passes Trump’s spending bill, which now moves to the Senate

Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science

The U.S. Senate has passed a stopgap spending bill that, in addition to avoiding a government shutdown at the end of September, would preclude the White House Office of Management and Budget from finalizing a proposal that seeks to fundamentally redraw the ground rules for all federally funded research (The Cancer Letter, Aug. 7, 2026).

Senate leaders introduce revised, bipartisan stopgap bill that would ban OMB from finalizing rule that would politicize science

The Senate has released its version of a 2027 continuing resolution that would fund the U.S. government through Dec. 11.

HRSA redrafts 340B rebate pilot program after courts block the original version

After returning to the drawing board, the Health Resources and Services Administration has announced a second iteration of the 340B Rebate Model Pilot Program, after it withdrew the original pilot earlier this year.

The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection

The Susan Wojcicki Foundation, a new entrant into health philanthropy, is taking on a critical mission: Advancing research into new approaches to early detection of lung cancer—redefining risk, expanding awareness, and accelerating innovation.

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

HHS and the Centers for Medicare & Medicaid Services deferred more than $1 billion in federal Medicaid payments to California and Minnesota as these states submit additional documentation supporting certain Medicaid claims.

July 24, 2026

Vol.52 No.29

By Jacquelyn Cobb

Podcast The Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.

June 26, 2026

Vol.52 No.25

By Paul Goldberg and Claire Marie Porter

House passes Trump’s spending bill, which now moves to the Senate

YOU MAY BE INTERESTED IN

Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science

Senate leaders introduce revised, bipartisan stopgap bill that would ban OMB from finalizing rule that would politicize science

HRSA redrafts 340B rebate pilot program after courts block the original version

The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

Renew today!

Subscriber content

Never miss an issue!

Login

House passes Trump’s spending bill, which now moves to the Senate

YOU MAY BE INTERESTED IN

Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science

Senate leaders introduce revised, bipartisan stopgap bill that would ban OMB from finalizing rule that would politicize science

HRSA redrafts 340B rebate pilot program after courts block the original version

The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions”

Never miss an issue!

Login

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”